express scripts holding co
(ESRX:NASDAQ GS)
As of 8:10 PM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).
Financial Statements for express scripts holding co (ESRX)
Year over year, Express Scripts Holding Company has seen little change in their bottom line (from $1.3B USD to $1.3B USD) despite revenues that grew from $46.1B USD to $93.9B USD. A key factor has been an increase in the percentage of sales devoted to SGA costs from 1.72% to 2.52%.
| Currency in Millions of US Dollars | As of: | Dec 31 2009 Restated | Dec 31 2010 Reclassified | Dec 31 2011 Restated | Dec 31 2012 | 4 Year Trend |
| Revenues | 24,722.3 | 44,973.2 | 46,128.3 | 93,858.1 |  | |
| TOTAL REVENUES | 24,722.3 | 44,973.2 | 46,128.3 | 93,858.1 | | |
| Cost of Goods Sold | 22,298.3 | 41,920.5 | 42,918.4 | 86,478.2 | | |
| GROSS PROFIT | 2,424.0 | 3,052.7 | 3,209.9 | 7,379.9 | | |
| Selling General & Admin Expenses, Total | 810.7 | 818.5 | 792.3 | 2,365.9 | | |
| Depreciation & Amortization, Total | 34.7 | 40.7 | 40.7 | 1,474.4 | | |
| OTHER OPERATING EXPENSES, TOTAL | 845.4 | 859.2 | 833.0 | 3,840.3 | | |
| OPERATING INCOME | 1,578.6 | 2,193.5 | 2,376.9 | 3,539.6 | | |
| Interest Expense | -194.4 | -167.1 | -299.7 | -619.0 | | |
| Interest and Investment Income | 5.3 | 4.9 | 12.4 | 10.6 | | |
| NET INTEREST EXPENSE | -189.1 | -162.2 | -287.3 | -608.4 | | |
| Income (Loss) on Equity Investments | -- | -- | -- | 14.9 | | |
| EBT, EXCLUDING UNUSUAL ITEMS | 1,389.5 | 2,031.3 | 2,089.6 | 2,946.1 | | |
| Merger & Restructuring Charges | -61.1 | -122.6 | -62.5 | -746.9 | | |
| Impairment of Goodwill | -- | -- | -- | -23.0 | | |
| Gain (Loss) on Sale of Assets | -- | -- | -- | 14.8 | | |
| Other Unusual Items, Total | -20.0 | -- | -- | -- | | |
| Insurance Settlements | 15.0 | -- | -- | -- | | |
| Legal Settlements | -35.0 | -- | -- | -- | | |
| EBT, INCLUDING UNUSUAL ITEMS | 1,308.4 | 1,908.7 | 2,027.1 | 2,191.0 | | |
| Income Tax Expense | 481.8 | 704.1 | 748.6 | 833.3 | | |
| Minority Interest in Earnings | -- | -- | -2.7 | -17.2 | | |
| Earnings from Continuing Operations | 826.6 | 1,204.6 | 1,278.5 | 1,357.7 | | |
| EARNINGS FROM DISCOUNTINUED OPERATIONS | 1.0 | -23.4 | -- | -27.6 | | |
| NET INCOME | 827.6 | 1,181.2 | 1,275.8 | 1,312.9 | | |
| NET INCOME TO COMMON INCLUDING EXTRA ITEMS | 827.6 | 1,181.2 | 1,275.8 | 1,312.9 | | |
| NET INCOME TO COMMON EXCLUDING EXTRA ITEMS | 826.6 | 1,204.6 | 1,275.8 | 1,340.5 | | |
| Recently Viewed | |||
| ESRX:US | $62.49 USD | +1.18 |  |
| Company | Last | Change |
| Cardinal Health Inc | $47.59 USD | -0.37 |
| CVS Caremark Corp | $58.70 USD | -0.81 |
| McKesson Corp | $117.55 USD | -0.86 |
| UnitedHealth Group Inc | $62.28 USD | -0.59 |
| Walgreen Co | $50.14 USD | +0.03 |
| View Industry Companies | ||
Industry Analysis
ESRX
Industry Average
| Valuation | ESRX | Industry Range |
| Price/Earnings | 35.3x |
|
| Price/Sales | 0.5x |
|
| Price/Book | 2.1x |
|
| Price/Cash Flow | 17.3x |
|
| TEV/Sales | 0.3x |
|
Post a JobJobs
- Florida | Express ScriptsPosted: May 22
- Florida | Express ScriptsPosted: May 11
- Minnesota | Express ScriptsPosted: May 21
- Missouri | Express ScriptsPosted: May 21
